BOSTON ONCOLOGY ARABIA

Serial Number 98087934
Registration 7374510
700

Registration Progress

Application Filed
Jul 17, 2023
Under Examination
Approved for Publication
Feb 13, 2024
Published for Opposition
Feb 13, 2024
Registered
Apr 30, 2024

Trademark Image

BOSTON ONCOLOGY ARABIA

Basic Information

Serial Number
98087934
Registration Number
7374510
Filing Date
July 17, 2023
Registration Date
April 30, 2024
Published for Opposition
February 13, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 30, 2024
Registration
Registered
Classes
042

Rights Holder

BOSTON ONCOLOGY ARABIA

16
Address
4147 WADI ASH SHATI, DORAT AL-GHADEER
BUILDING, 8646, OFFICE 23
RIYADH 13311
SA

Ownership History

Boston Oncology, LLC

Original Applicant
16
Cambridge, MA

BOSTON ONCOLOGY ARABIA

New Owner Before Publication #1
16
RIYADH SA

BOSTON ONCOLOGY ARABIA

Owner at Publication
16
RIYADH SA

BOSTON ONCOLOGY ARABIA

Original Registrant
16
RIYADH SA

Legal Representation

Attorney
Garfield Goodrum

USPTO Deadlines

Next Deadline
1736 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-30)
Due Date
April 30, 2030
Grace Period Ends
October 30, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Apr 30, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 30, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 13, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 13, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 24, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 10, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 7, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 7, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 7, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 15, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 7, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 6, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 6, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 6, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 16, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 15, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 31, 2023 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Jul 31, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jul 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
pharmaceutical research and development; consultation in the field of pharmaceutical research and development
First Use Anywhere: Sep 1, 2021
First Use in Commerce: Sep 1, 2021

Additional Information

Design Mark
The mark consists of a logo comprised of 4 circles, one larger than the other 3 and the 3 drawn on the circumference of the larger at the upper- and lower-right quadrants and the lower-left quadrant, positioned to the left of the terms BOSTON ONCOLOGY ARABIA.
Color Claim
Color is not claimed as a feature of the mark.
Other
As to "BOSTON ONCOLOGY"

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ARABIA"